CLIENT LOGIN

The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stagebreast cancer

PUBLICATION:SABCS 2020AUTHORS:Laura Lee, Sami Diab, Julie Barone, Jennifer A. Crozier, Read More

2021-06-03T14:19:13-07:00December 29th, 2020|Evidence, Uncategorized|

The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence risk in older patients

PUBLICATION: SABCS 2020 AUTHORS:Iris Noordhoek, Esther Bastiaannet, Ersan Lujinovic, Laura Read More

2021-03-08T16:26:00-08:00December 10th, 2020|Evidence, Uncategorized|

MammaPrint and BluePrint NGS Results are Robust and Accurate for Patients with Early Stage Breast Cancer

  PUBLICATION: AMP 2020 AUTHORS: Douglas Kingma, Kasey Lawrence, Sahra Read More

2021-07-07T12:54:52-07:00November 17th, 2020|Evidence, Uncategorized|
Go to Top